Intellia Therapeutics On March 19, Notified Regeneron Pharmaceuticals That Co Is Opting Out Of Its Factor IX Co-Development And Co-Funding Agreement
Intellia Therapeutics于3月19日通知Regeneron Pharmicals,该公司选择退出其Factor IX共同开发和联合资助协议
Intellia Therapeutics On March 19, Notified Regeneron Pharmaceuticals That Co Is Opting Out Of Its Factor IX Co-Development And Co-Funding Agreement
Intellia Therapeutics于3月19日通知Regeneron Pharmicals,该公司选择退出其Factor IX共同开发和联合资助协议
使用浏览器的分享功能,分享给你的好友吧